| Literature DB >> 35160071 |
Cristina Beatrice Spigariolo1,2, Serena Giacalone1,2, Gianluca Nazzaro1.
Abstract
Maskne, a newly coined term deriving from the contraction of mask-related acne, is a form of mechanical acne resulting from continuous textile-skin adherence and friction. Prolonged mask use heats up the face environment, thus modifying skin microbiota and sebum production. Although effective prevalence is unknown, since the pandemic began and the prolonged use of masks was extended to the general population, maskne has been a frequent topic of consultation among dermatologists. This term has been successfully introduced into common language, with more than 200,000 hashtags on social media, where it is also possible to find "home remedies" that can worsen this dermatosis. The aim of this paper is to discuss the pathogenesis, address clinicians on the correct differential diagnoses among facial dermatoses, and move towards the correct therapy.Entities:
Keywords: COVID-19; SARS-CoV-2; acne; facial dermatosis; mask; maskne; pandemic
Year: 2022 PMID: 35160071 PMCID: PMC8836723 DOI: 10.3390/jcm11030618
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Topical therapies in acne.
| Topical Agents | Effects | Type of Acne | Role in |
|---|---|---|---|
| Benzoyl Peroxide (BP) 2.5–10% | Antibacterial | Mild papulopustular and mixed acne | Risk of irritation under mechanical occlusion |
| Topical antibiotics (AB) (e.g., Erythromycin 2% and Clindamycin 1%) | Antibacterial: high risk of bacterial resistances in monotherapy | Mild papulopustular acne | Useful |
| Fixed combinations of BP and topical antibiotics | See above BP+ | Mild-moderate papulopustular and mixed acne | |
| Topical retinoids (e.g., Tretinoin 0.025–0.1%, Adapalene 0.1–0.3%; Tazarotene 0.05–0.1%, Trifaroten 0.005%) | Comedolytic | Comedonal acne | Risk of irritation under mechanical occlusion |
| Fixed combinations of retinoids and AB or PB | See above | Mild-moderate papulopustular and mixed acne | Hydrogel carrier formulations minimize local irritation [ |
| Azelaic agent 20% | Mildly effective as: | Mild comedonal acne | No experience |
| Dapsone 5% gel | Unknown mechanism | Inflammatory acne, particularly in adult females with acne (poorly used) | |
| Salicylic acid 0.5–2% | Comedolytic | Mild comedonal acne | Risk of irritation |
Systemic therapies in acne.
| Drugs | Dosage | Notes |
| |
|---|---|---|---|---|
| Antibiotics | Doxycycline | 50 mg bid | Not in children | Especiallyuseful for antinflammatory effect |
| Minocycline | 50 mg/die or bid | |||
| Tetracycline | 250–500 mg bid | |||
| Azithromicyn | 500 mg three times/week | Children | ||
| Trimethoprim-sulfamethoxazole | 160 mg/800 mg once to twice daily | Adults resistant to tetracycline/macrolides | No reports | |
| Isotretinoin | 0.5–1.0 mg/kg/die | Periodic monitoring of liver function tests, serum cholesterol, and triglycerides | ||
| Hormonal agents | Oral contraceptives | According to the molecules | Only for women | |
| Spironolactone | 50–100 mg/die | |||